These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9248966)
1. Therapeutic monitoring, the concentration-effect relationship and impact on the clinical efficacy of antibiotic agents. Dawson SJ; Reeves DS J Chemother; 1997 May; 9 Suppl 1():84-92. PubMed ID: 9248966 [TBL] [Abstract][Full Text] [Related]
2. [Monitoring of antibiotic treatment of patient with a severe bacterial infection]. Aubert G; Carricajo A Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959 [TBL] [Abstract][Full Text] [Related]
3. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles. Klutman NE Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616 [TBL] [Abstract][Full Text] [Related]
4. Choosing an antibiotic on the basis of pharmacodynamics. Craig WA Ear Nose Throat J; 1998 Jun; 77(6 Suppl):7-11; discussion 11-2. PubMed ID: 9674328 [TBL] [Abstract][Full Text] [Related]
5. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
7. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae. Knudsen JD Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659 [TBL] [Abstract][Full Text] [Related]
8. Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics. Nightingale CH Pharmacotherapy; 2005 Dec; 25(12 Pt 2):146S-149S. PubMed ID: 16305285 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. McKellar QA; Sanchez Bruni SF; Jones DG J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444 [TBL] [Abstract][Full Text] [Related]
10. Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations. Turnidge JD Scand J Infect Dis Suppl; 1990; 74():137-41. PubMed ID: 2097701 [TBL] [Abstract][Full Text] [Related]
11. Treatment options in odontogenic infection. Maestre-Vera JR Med Oral Patol Oral Cir Bucal; 2004; 9 Suppl():25-31; 19-24. PubMed ID: 15580134 [TBL] [Abstract][Full Text] [Related]
12. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens. McCormack JP; Schentag JJ Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911 [TBL] [Abstract][Full Text] [Related]
13. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy. Gumbo T Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological indices in antibiotic therapy. Barger A; Fuhst C; Wiedemann B J Antimicrob Chemother; 2003 Dec; 52(6):893-8. PubMed ID: 14613960 [TBL] [Abstract][Full Text] [Related]